SecondWave Systems Secures $7M Series A to Advance Noninvasive Ultrasound Therapy for Inflammatory Diseases

SecondWave Systems, Inc., a clinical stage medical device company developing a novel ultrasound-based treatment for inflammatory disorders, announced tha...

April 09, 2025 | Wednesday | News
China, India, and Africa at the Forefront as Type 5 Diabetes Gains Global Recognition

Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now offici...

April 09, 2025 | Wednesday | Reports
HNL Lab Medicine Partners with Northampton County to Offer Free Lead Testing for Children

HNL Lab Medicine, in partnership with Northampton County, is making it easier for families to access lead testing for children. Lead exposure remains a ser...

April 08, 2025 | Tuesday | News
Pillar Biosciences Secures U.S. Nationwide Medicare Coverage for oncoReveal® CDx Pan-Cancer NGS Kit

 Pillar Biosciences, Inc., the leader in Decision Medicine™,  announced they have received nationwide Medicare coverage by the Centers fo...

April 04, 2025 | Friday | News
Singapore’s NUS Integrates AI and 3D Bioprinting to Transform Personalised Gum Tissue Grafts

Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resourc...

April 04, 2025 | Friday | Reports
FDA Approves Freeze-Dried Formulation of JYNNEOS® for Smallpox and Mpox Prevention

Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS® (Smallpox and...

April 01, 2025 | Tuesday | News
Novo Nordisk’s Semaglutide 2.4 mg Linked to 57% Reduction in Cardiovascular Events in Real-World SCORE Study

Novo Nordisk announced new findings from the retrospective, observational SCORE study, demonstrating that treatment with semaglutide 2.4 mg was associate...

March 31, 2025 | Monday | News
Lilly’s Lepodisiran Shows 94% Reduction in Lipoprotein(a) in Phase 2 Trial, Advancing Hope for Genetic Heart Risk Treatment

Eli Lilly and Company announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the ...

March 31, 2025 | Monday | News
Eli Lilly Expands LillyDirect Platform to Improve Access to Alzheimer's Disease Care in the U.S.

Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent in-person and telehealth opti...

March 28, 2025 | Friday | News
Sanofi’s mRNA Chlamydia Vaccine Candidate Receives Fast Track Designation from FDA

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. ...

March 28, 2025 | Friday | News
Merck and Hengrui Pharma Forge $1.97 Billion Global Partnership to Advance Novel Lp(a) Inhibitor for Cardiovascular Disease

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a ...

March 26, 2025 | Wednesday | News
GSK Wins FDA Approval for Blujepa, First New Oral Antibiotic for UTIs in Nearly 30 Years

GSK plc announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg...

March 26, 2025 | Wednesday | News
B. Braun Launches 3 g Cefazolin in DUPLEX® for Surgical Infection Prevention

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazol...

March 25, 2025 | Tuesday | News
Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close